Evidence-based psychotherapy of chronic depressive disorders;Evidenzbasierte psychotherapie der chronischen depression

PPmP Psychotherapie Psychosomatik Medizinische Psychologie

Volumn 58, Issue 5, 2008, Pages 215-224

  Hecht, Heide ^a   Van Calker, Dietrich ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; DEPRESSION; DYSTHYMIA; EVIDENCE BASED MEDICINE; HUMAN; INTERVENTION STUDY; PRIORITY JOURNAL; PSYCHOTHERAPY; REVIEW; THERAPY EFFECT;

CHRONIC DISEASE; COGNITIVE THERAPY; DEPRESSIVE DISORDER, MAJOR; DYSTHYMIC DISORDER; EVIDENCE-BASED MEDICINE; FOLLOW-UP STUDIES; HUMANS; PSYCHOTHERAPY; RECURRENCE;

EID: 44649187863     PISSN: 09372032     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-986355     Document Type: Review

References (22)

1. McCullough P. Psychotherapie der chronischen Depression. Cognitive Behavioral Analysis System of Psychotherapy - CBASP. München, Jena: Urban & Fischer, 2006
2. Klerman GL, Weissman MM, Rounsaville BJ, Chevron ES. Interpersonal psychotherapy of depression. New York: Basic Books Inc., Publisher, 1984
3. Schramm E (Hrsg). Interpersonelle Psychotherapie bei Depressionen und anderen psychischen Störungen. Stuttgart: Schattauer, 1998
4. Markowitz JC. Interpersonal psychotherapy for chronic depression. JCLP 2003; 59: 847-858
5. Schramm E. Interpersonelle Psychotherapie bei chronischen Depressionen. In: Bschor T (Hrsg): Behandlungsmanual therapieresistente Depression. Stuttgart: Kohlhammer, 2008 (im Druck)
6. Beck AT, Rush AJ, Shaw BF, Emery G. Kognitive Therapie der Depression. Weinheim: Beltz PVU, 1996
7. Lewinson PM. A behavioral approach to depression. In: Friedmann RJ, Katz MM (eds): The psychology of depression. New York: Wiley, 1974
8. AHCPR Agency for Health Care Policy and Research. Clinical Practice Guideline No. 1. AHCPR Publication, 1993 No. 92-0023
9. Ravindran AV, Anismen H, Merali Z et al. Treatment of primary dysthymia with group cognitive therapy and pharmacotherapy: clinical symptoms and functional impairments. Am J Psychiatry 1999; 156: 1608-1617
10. Markowitz JC, Kocsis JH, Bleiberg KL et al. A comparative trial of psychotherapy and pharmacotherapy for "pure" dysthymic patients. J Affect Dis 2005; 89: 167-175
11. Browne G, Steiner M, Roberts J et al. Sertraline and/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6-month comparison with longitudinal 2-year follow-up of effectiveness and costs. J Affect Dis 2002; 68: 317-330
12. Dunner DI, Schmaling KB, Hendrickson H et al. Cognitive therapy versus fluoxetin in the treatment of dystymic disorder. Depression 1996; 4: 34-41
13. deMello MF, Myczcowsk LM, Menezes PR. A randomized controlled trail comparing moclobemid and moclobemid plus interpersonal psychotherapy in the treatment of dysthymic disorder. J Psychother Pract Res 2001; 10: 117-123
14. Hellerstein DJ, Little SAS, Samstag LW et al. Adding group psychotherapy to medication treatment in dysthymia. A randomized prospective pilot study. J Psychother Pract Res 2001; 10: 93-103
15. Agosti V, Ocepek-Wwelikson K. The efficacy of imipramine and psychotherapy in early-onset chronic depression: a reanalysis of the National Instiute of Mental Health Treatment of Depression Collaborative Research Program. J Affect Dis 1997; 43: 181-186
16. Keller MB, McCullough JP, Klein DN et al. A comparison of Nefazodon, the Cognitive Behavioral-Analysis System of Psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med 2000; 342: 1462-1470
17. Miller IW, Norman WH, Keitner GI. Combined treatment for patients with double depression. Psychother Psychosom 1999; 68: 180-185
18. Schramm E, Schneider D, Zobel I et al. Efficacy of interpersonal psychotherapy plus pharmacotherapy in chronically depressed inpatients. J Affect Disord 2008 (im Druck)
19. Schatzberg AF, Rush A, Arnow BA et al. Chronic depression. Medication (Nefazodon) or psychotherapy (CBASP) is effective when the other is not. Arch Gen Psychiatry 2005; 62: 513-520
20. Kocsis JH, Rush AJ, Markowitz JC et al. Continuation treatment of chronic depression: a comparison of Nefazodon, Cognitive Behavioral Analyssis System of Psychotherapy, and their combination. Psychopharmacol Bull 2003; 37: 73-87
21. Perlis RH, Nierenberg AA, Alpert JE et al. Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorder. J Clin Psychopharmacol 2002; 22: 474-480
22. Klein DN, Arnow BA, Blalock JA et al. Cognitive-Behavioral Analysis System of Psychotherapy as a maintenance treatment for chronic depression. J Consult Clin Psychol 2004; 72: 681-688